U.S. Specialized REITs Stock News

Q1 earnings reset expectations, but losses continue Lumen Technologies (LUMN) reported first quarter 2026 sales of US$2,899 million, compared with US$3,182 million a year earlier. Net loss was US$200 million versus US$201 million, keeping loss per share steady at US$0.20. See our latest analysis for Lumen Technologies. The share price has been volatile around these Q1 results, with a 1 month share price return of 32.05% and a 90 day share price return of 39.22%. The 1 year total shareholder...

Revvity Q1 2026 earnings snapshot Revvity (RVTY) has just put fresh numbers on the table, with recent quarters showing revenue between US$664.8 million and US$772.1 million and basic EPS ranging from US$0.35 to US$0.85 as the company heads into its Q1 2026 update. Over the past year, revenue has been recorded from US$684.0 million in Q3 2024 up to US$772.1 million in Q4 2025, while basic EPS prints in that stretch run from US$0.35 to US$0.85, giving investors a clear view of how the top line...

Why Fermi (FRMI) is on investors’ radar Fermi (FRMI) has been drawing attention after recent share price moves, with the stock last closing at $4.94 and a market value around $3.19b. This has put its AI-focused power campus model in sharper focus. See our latest analysis for Fermi. Recent trading has been weak, with a 1 day share price return of a 2.56% decline adding to a 90 day share price return of a 39.61% decline. This suggests negative momentum as investors reassess growth prospects and...

In late April 2026, Monolithic Power Systems reported first-quarter 2026 revenue of US$804.19 million and net income of US$193.23 million, raised second-quarter revenue guidance to US$890–910 million with GAAP gross margin of 55.1–55.7%, and secured a favorable resolution of a Bel Power patent lawsuit with US$50,000 in court costs awarded. Beyond the headline beats, the quarter underscored how Monolithic Power Systems’ enterprise data and communications power solutions, backed by...

Clinical partnership puts Vir Biotechnology in focus Vir Biotechnology (VIR) has drawn fresh attention after finalizing its collaboration with Astellas Pharma on VIR-5500 for prostate cancer and treating the first patient in an expansion cohort of its Phase 1 metastatic prostate cancer trial. See our latest analysis for Vir Biotechnology. The recent collaboration news comes against a backdrop of strong momentum, with a 30 day share price return of 10.49% and a year to date share price return...

Two Harbors Investment (NYSE:TWO) is the subject of a takeover battle involving competing bids from UWM Holdings and CrossCountry Mortgage. The board of NYSE:TWO has rejected multiple acquisition attempts from UWM Holdings and is backing a fully financed, all-cash offer from CrossCountry Mortgage. The contest now centers on a shareholder vote, proxy solicitations, and competing arguments about value, deal structure, and execution risk. For you as a NYSE:TWO shareholder, this is not a...

Wondering if Ally Financial at around US$43 per share still offers value, or if most of the easy gains are behind it, starts with understanding what the current price is actually reflecting. The stock has had mixed recent returns, with a 2.7% decline over the last week, an 8.5% gain over the last month, a 5.6% decline year to date, and a 36.8% return over the last year alongside an 88.9% three year return and a 2.9% five year decline. Recent coverage has focused on how Ally Financial fits...

Avista’s Q1 2026 earnings in focus Avista (AVA) has rolled into Q1 2026 on the back of a solid run through 2025, capped by Q4 revenue of US$533 million and basic EPS of US$0.87, alongside trailing 12 month EPS of US$2.38 on US$1.96 billion of revenue. Over recent quarters, the company has seen revenue hold in a US$394 million to US$617 million range while quarterly EPS moved between US$0.17 and US$0.98. The trailing net profit margin is 9.8% compared with 9.3% a year earlier, which puts the...

In the past quarter, Adaptive Biotechnologies reported first‑quarter 2026 revenue of US$70.87 million, up from US$52.44 million a year earlier, while narrowing its net loss to US$20.03 million and reducing basic loss per share from US$0.20 to US$0.13. The results were powered by Minimal Residual Disease testing, with clonoSEQ volumes rising strongly and management raising full‑year 2026 MRD revenue guidance to US$260–US$270 million, underscoring the segment’s growing importance to the...

Why Mirion’s latest guidance update matters for shareholders Mirion Technologies (MIR) reaffirmed its 2026 guidance for 22% to 24% revenue growth, supported by foreign exchange and acquisition tailwinds, after reporting higher first quarter revenue and a GAAP net loss of US$3.4 million. See our latest analysis for Mirion Technologies. The reaffirmed revenue growth guidance and recent quarterly update come after a mixed share price run, with a 7 day share price return of 7.82% and a 3 year...

AGCO (AGCO) has just opened Q1 2026 earnings season with recent quarterly numbers that plot a sharp swing in profitability, moving from a Q4 2024 net loss of US$255.7 million on US$2,887.3 million of revenue and EPS of US$3.43 loss, to Q4 2025 net income of US$95.5 million on US$2,920.2 million of revenue and EPS of US$1.29. Over the same period, trailing twelve month EPS shifted from a US$5.69 loss on US$11.7 billion of revenue to US$9.76 on US$10.1 billion. Revenue moved from US$2,599.3...

Neogen recently disclosed that Chief Legal Officer Stacey Jennifer Evans received 39,349 restricted shares and 89,520 stock options on 1 May 2026, with the options priced at US$9.53 and vesting over three years. These equity grants arrive as Neogen contends with falling sales, shrinking returns on capital, and ongoing EBITDA losses that may pressure its financing options. Against this backdrop of declining sales and EBITDA losses, we’ll now assess how these developments reshape Neogen’s...

Event driven snapshot of Flywire Flywire (FLYW) has drawn investor attention after a recent move in the stock, with the price up 2.18% on the day and gains over the past week, month, and past 3 months. See our latest analysis for Flywire. The recent 7-day and 30-day share price returns of 7.0% and 23.34%, alongside a 1-year total shareholder return of 44.72% but a 3-year total shareholder return loss of 49.65%, suggest that short-term momentum has picked up after a tougher longer period for...

In late April 2026, Opera Limited reported past first-quarter 2026 results showing sales of US$175.77 million and net income of US$24.79 million, alongside higher basic and diluted EPS of US$0.27 from continuing operations. On the same day, Opera raised its full-year 2026 revenue outlook to US$727 million–US$740 million and projected robust double-digit year-over-year growth for both the second quarter and the full year, highlighting management’s confidence in the business. With Opera...

Investors may be wondering if ConocoPhillips at around US$123.32 still offers value after a strong run, or if recent enthusiasm has already been priced in. The stock has seen a 27.5% return year to date and 45.5% over the last year, even though the last 7 days and 30 days showed returns of a 0.8% decline and a 5.5% decline, respectively. Recent coverage has focused on ConocoPhillips as a major integrated energy producer, with attention on how it is positioning its portfolio and capital...

Pinnacle Financial Partners, Inc. has already reported first‑quarter 2026 results, with net income rising to US$150 million from US$140 million a year earlier, while basic and diluted earnings per share from continuing operations fell to US$0.89 from about US$1.78 and US$1.77, respectively. This combination of higher total profit but sharply lower per‑share earnings, alongside AI-driven trading showing mixed time‑horizon sentiment, adds complexity to how investors may interpret Pinnacle’s...

Strategy Inc. (NasdaqGS:MSTR) is shifting from a "never sell" approach to its Bitcoin holdings to actively considering Bitcoin sales. Executives, including Michael Saylor and CEO Phong Le, outlined a more flexible policy aimed at funding dividends, managing capital, and maximizing Bitcoin per share. This marks a significant change in how the company runs what is described as the world’s largest corporate Bitcoin treasury. For shareholders, the timing of this policy change comes after a...

AnaptysBio recently reported that the Delaware Chancery Court dismissed Tesaro’s anticipatory breach of contract claim over their Jemperli collaboration, while CEO Daniel Faga is set to discuss the company’s royalty assets at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on May 6, 2026. This legal outcome, combined with a stronger earnings outlook highlighted by an upgraded Zacks rank, strengthens AnaptysBio’s position around its Jemperli-related royalty rights. We’ll now...

Abbott Laboratories stock: context after recent performance Abbott Laboratories (ABT) stock has faced pressure recently, with negative returns over the past week, month, past 3 months, year to date, and past year, drawing investor attention to the company’s fundamentals and valuation. See our latest analysis for Abbott Laboratories. The recent 7 day share price return of 7.13% and 30 day share price return of 15.26% add to a year to date share price decline of 29.81%. Meanwhile, the 1 year...

In the first quarter of 2026, Molson Coors Beverage Company reported year-on-year increases in sales to US$2,717.9 million, revenue to US$2,351.1 million, and net income to US$151.3 million, with basic earnings per share from continuing operations rising to US$0.80. The company coupled these stronger results with a three-year US$450 million cost-savings program, continued integration of Monaco Cocktails, and reaffirmed full-year 2026 guidance despite ongoing volume and cost pressures. We’ll...

AGNC Investment (AGNC) opened 2026 with a softer quarter, reporting Q1 total revenue of a loss of US$114 million and a basic EPS loss of US$0.17, set against trailing twelve month revenue of US$1.6 billion and EPS of US$1.22. Over recent periods the company has seen quarterly revenue move from US$154 million in Q4 2024 to US$995 million in Q4 2025, with basic EPS shifting from US$0.10 to US$0.83 over the same span. Trailing twelve month revenue rose from US$973 million in Q4 2024 to US$1.8...

On 27 April 2026, Greenland Energy Company announced an agreement with Halliburton to provide integrated consulting, comprehensive well services, and logistical management for the first onshore exploration wells in Greenland’s Jameson Land Basin. This collaboration places Halliburton at the center of an emerging Arctic oil campaign, tying its expertise to a large, unexplored basin with significant discovery potential and complex logistics requirements. We’ll now explore how securing a...

Alphatec Holdings (ATEC) is back in focus after reporting first quarter 2026 results, with a net loss of US$33.91 million and basic loss per share of US$0.22 from continuing operations. See our latest analysis for Alphatec Holdings. At a share price of US$10.23, Alphatec Holdings has seen a 9.41% 7 day share price return but a 50.72% year to date share price decline. The 1 year total shareholder return is 15.94% lower, suggesting recent momentum has faded despite interest around the Q1 2026...

In late April 2026, The Scotts Miracle-Gro Company reported past second-quarter results showing US$1,459.5 million in sales and US$238.6 million in net income, with both basic and diluted earnings per share from continuing operations increasing year over year. Alongside these results, Scotts Miracle-Gro reaffirmed its fiscal 2026 outlook and outlined its SMG 2.0 plan targeting meaningful growth, higher margins, lower leverage, and a multi-year share repurchase program that together could...